Exchange of Safety Information. 11.1 The Parties shall keep each other informed on all reports including publications of adverse events coming to either Party’s knowledge with regard to Perifosine and/or Contract Product, regardless of the origin of such reports.
Appears in 2 contracts
Samples: Aeterna Zentaris Inc., Aeterna Zentaris Inc.
Exchange of Safety Information. 11.1 14.1 The Parties shall keep each other informed on all reports including publications of adverse events coming to either Party’s knowledge with regard to Perifosine and/or Contract ProductLicensed Products, regardless of the origin of such reports, in accordance with a separate pharmacovigilance agreement for the operation by each Party of a pharmacovigilance system and the exchange of safety and pharmacovigilance data to be concluded in due time between the Parties prior to Licensee’s initiation of any clinical activities for the Licensed Product in the Territory.
Appears in 1 contract
Exchange of Safety Information. 11.1 The Parties shall keep each other informed on all reports including publications of adverse events coming to either Party’s knowledge with regard to Perifosine Contract Products and/or Contract ProductD-63153, regardless of the origin of such reports.
Appears in 1 contract
Samples: License and Collaboration Agreement (Spectrum Pharmaceuticals Inc)
Exchange of Safety Information. 11.1 The Parties shall keep each other informed on all reports including publications of adverse events coming to either Party’s 's knowledge with regard to Perifosine and/or Contract Product, regardless of the origin of such reports.
Appears in 1 contract
Samples: Keryx Biopharmaceuticals Inc